S&P Futures
4,136.50+3.75(+0.09%)Dow Futures
33,579.00+9.00(+0.03%)Nasdaq Futures
13,981.00+5.25(+0.04%)
1Life Healthcare, Inc. (ONEM)
Chart Events
Performance Outlook
| Previous Close | 41.62 |
| Open | 41.99 |
| Bid | 0.00 x 2900 |
| Ask | 0.00 x 1100 |
| Day's Range | 41.62 - 42.80 |
| 52 Week Range | 18.59 - 59.82 |
| Volume | 545,633 |
| Avg. Volume | 1,377,263 |
| Market Cap | 5.695B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.76 |
| Earnings Date | Feb 25, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 54.67 |
Fair Value
Related Research
- GlobeNewswire
1Life Healthcare (One Medical) Announces Date of its First Quarter 2021 Results Conference Call
SAN FRANCISCO, April 13, 2021 (GLOBE NEWSWIRE) -- 1Life Healthcare, Inc. (One Medical) (Nasdaq: ONEM) today announced that its first quarter 2021 results will be released on Wednesday, May 12, 2021, after the close of the market. The company will host a conference call on the same day at 1:30 p.m. (PT) / 4:30 p.m. (ET) to discuss its financial results. A live audio webcast will be available online at https://investor.onemedical.com. The conference call can also be accessed by dialing 1-800-258-1651 for U.S. participants, or 1-612-979-9928 for international participants, and referencing conference ID 3528659. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days. About One MedicalOne Medical is a membership-based and technology-powered primary care platform with seamless digital health and inviting in-office care, convenient to where people work, shop, live, and click. Our vision is to delight millions of members with better health and better care while reducing costs. Our mission is to transform health care for all through our human-centered, technology-powered model. Headquartered in San Francisco, 1Life Healthcare, Inc. is the administrative and managerial services company for the affiliated One Medical physician owned professional corporations that deliver medical services in-office and virtually. 1Life and the One Medical entities do business under the “One Medical” brand. Investor Contact:Rose Salzwedel, One MedicalDirector of Investor Relationsinvestor@onemedical.com 206-331-2211 Media Contact:Kristina Skinner, One MedicalSr. Director of External Communicationspress@onemedical.com650-743-5187
- MarketWatch
Teladoc, 1Life stocks are still bullish after Amazon Care's rollout leads to selloff, analyst says
Shares of Teladoc Health Inc. and One Medical-parent 1Life Healthcare Inc. extended losses Thursday, in the wake of Amazon.com Inc. announcement on Wednesday that it will be rolling out its Amazon Care telemedicine program nationwide. Teledoc's stock slumped 2.3% in afternoon trading, after shedding 4.4% on Wednesday, while 1Life shares slid 4.1% after losing 0.8% the day before. "Clearly, competition has increased, and we do not discount Amazon's potential for success," Canaccord Genuity analyst Richard Close wrote in a note to clients. Of the companies he covers, Close said competition will be greatest for Teladoc and One Medical, but noted that it doesn't mean investors should give up on the companies. "In the past, rumblings of Amazon's healthcare services interests have been buying opportunities," Close wrote. He recommended his buy ratings on Teladoc and 1Life, saying he does not believe the Amazon Care news has materially damaged the near-term opportunity for solid growth. "There should be ample opportunities for sustained growth going forward," he wrote. Teladoc's stock has lost 5.4% over the past three months and 1Life shares have ticked up 0.4%. In comparison, Amazon's stock has slipped 3.8% over the same time, while the SPDR Health Care Select Sector ETF has edged up 2.2% and the S&P 500 has gained 6.7%.
- Benzinga
One Medical Under Investigation By House Subcommittee, Allegedly Let Subscribers Cut COVID-19 Vaccine Line
One Medical, a subscription-based concierge health care provider, is now under investigation by a Congressional committee, accused of administering COVID-19 vaccines to family, friends, executives and wealthy clients, according to CNBC. What Happened: One Medical is owned by 1life Healthcare Inc. (NASDAQ: ONEM). As the supply of COVID-19 vaccines remains scarce, the elderly, those at high risk and frontline workers are top priority for receiving the vaccine. In a letter written by the Rep. James Clyburn, chairman of the House Select Subcommittee on the Coronavirus Crisis, One Medical is asked to provide documentation on its vaccine allocation process. “One Medical reportedly prioritized appointments for friends and family of the company’s leadership, an executive at a partner organization, and work-from-home staff at the company’s headquarters—none of whom were eligible under state and local guidelines,” the South Carolina Democrat wrote. “Prior to January 14, 2021, the company failed to require patients to answer a question about eligibility when registering for vaccination appointments. Since then, the company reportedly has not enforced requirements to provide proof of eligibility and has even allowed some patients who stated they were not in an eligible category to still book vaccination appointments.” One Medical Responds: To subscribe to One Medical, users pay $199 annually to be on the platform and receive VIP health care treatment in their area, with access to automated appointment scheduling and booking. "We remain committed to serving our communities and hope that this report does not impede our ability to continue doing this vital work," One Medical said in a statement on Twitter. ONEM Price Action: 1life Healthcare shares were down 5.72% at $46.01 at last check Tuesday. See more from BenzingaClick here for options trades from BenzingaNBA Top Shot, CryptoPunks And More: What You Need To Know About NFTsKevin O'Leary Starts Day Trading, Says Reddit Users 'Aren't Stupid'© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
